316 related articles for article (PubMed ID: 19433112)
1. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein.
Kaku Y; Noguchi A; Marsh GA; McEachern JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
J Virol Methods; 2009 Sep; 160(1-2):7-13. PubMed ID: 19433112
[TBL] [Abstract][Full Text] [Related]
2. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase.
Kaku Y; Noguchi A; Marsh GA; Barr JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
J Virol Methods; 2012 Jan; 179(1):226-32. PubMed ID: 22115786
[TBL] [Abstract][Full Text] [Related]
3. Development of a neutralization assay for Nipah virus using pseudotype particles.
Tamin A; Harcourt BH; Lo MK; Roth JA; Wolf MC; Lee B; Weingartl H; Audonnet JC; Bellini WJ; Rota PA
J Virol Methods; 2009 Sep; 160(1-2):1-6. PubMed ID: 19559943
[TBL] [Abstract][Full Text] [Related]
4. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
5. Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody.
Bae SE; Kim SS; Moon ST; Cho YD; Lee H; Lee JY; Shin HY; Lee HJ; Kim YB
Biochem Biophys Res Commun; 2019 Jun; 513(4):781-786. PubMed ID: 30995971
[TBL] [Abstract][Full Text] [Related]
6. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
[TBL] [Abstract][Full Text] [Related]
7. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
[TBL] [Abstract][Full Text] [Related]
8. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
Zhu W; Smith G; Pickering B; Banadyga L; Yang M
Viruses; 2024 May; 16(5):. PubMed ID: 38793674
[TBL] [Abstract][Full Text] [Related]
10. Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
Thakur N; Conceicao C; Isaacs A; Human S; Modhiran N; McLean RK; Pedrera M; Tan TK; Rijal P; Townsend A; Taylor G; Young PR; Watterson D; Chappell KJ; Graham SP; Bailey D
J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33054904
[TBL] [Abstract][Full Text] [Related]
11. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.
Dong J; Cross RW; Doyle MP; Kose N; Mousa JJ; Annand EJ; Borisevich V; Agans KN; Sutton R; Nargi R; Majedi M; Fenton KA; Reichard W; Bombardi RG; Geisbert TW; Crowe JE
Cell; 2020 Dec; 183(6):1536-1550.e17. PubMed ID: 33306954
[TBL] [Abstract][Full Text] [Related]
12. Vaccines to Emerging Viruses: Nipah and Hendra.
Amaya M; Broder CC
Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
[TBL] [Abstract][Full Text] [Related]
13. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.
Khetawat D; Broder CC
Virol J; 2010 Nov; 7():312. PubMed ID: 21073718
[TBL] [Abstract][Full Text] [Related]
14. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
15. Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.
Di Rubbo A; McNabb L; Klein R; White JR; Colling A; Dimitrov DS; Broder CC; Middleton D; Lunt RA
J Virol Methods; 2019 Dec; 274():113731. PubMed ID: 31513861
[TBL] [Abstract][Full Text] [Related]
16. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
[TBL] [Abstract][Full Text] [Related]
17. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
18. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.
Zhu Z; Bossart KN; Bishop KA; Crameri G; Dimitrov AS; McEachern JA; Feng Y; Middleton D; Wang LF; Broder CC; Dimitrov DS
J Infect Dis; 2008 Mar; 197(6):846-53. PubMed ID: 18271743
[TBL] [Abstract][Full Text] [Related]
19. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
20. Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus.
McNabb L; Barr J; Crameri G; Juzva S; Riddell S; Colling A; Boyd V; Broder C; Wang LF; Lunt R
J Virol Methods; 2014 May; 200():22-8. PubMed ID: 24508193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
